GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160 | -71.6% | 42,319 | -67.7% | 0.01% | -75.0% |
| Q1 2023 | $564 | +66.4% | 131,146 | +52.2% | 0.06% | +33.3% |
| Q4 2022 | $339 | -99.9% | 86,154 | +3.9% | 0.04% | -27.6% |
| Q3 2022 | $440,000 | +263.6% | 82,946 | +349.4% | 0.06% | +222.2% |
| Q2 2022 | $121,000 | -4.0% | 18,457 | +4.0% | 0.02% | +12.5% |
| Q4 2021 | $126,000 | – | 17,739 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $32,535,983 | 3.92% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $4,018,570 | 0.79% |
| Artal Group S.A. | 2,814,191 | $11,060 | 0.62% |
| SVB FINANCIAL GROUP | 52,920 | $207,976 | 0.57% |
| PFM Health Sciences, LP | 2,903,192 | $11,409,545 | 0.41% |
| Cheyne Capital Management (UK) LLP | 51,126 | $200,925 | 0.35% |
| HighVista Strategies LLC | 138,880 | $545,798 | 0.32% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,005,691 | 0.25% |
| SECTORAL ASSET MANAGEMENT INC | 273,787 | $1,075,983 | 0.21% |
| Yiheng Capital Management, L.P. | 1,186,295 | $4,662,139 | 0.21% |